advertisement
Li N 17
Showing records 1 to 17 | Display all abstracts from Li N127565 Outcomes of laser peripheral iridotomy in subgroups of primary angle closure disease eyes according to swept-source optical coherence tomography parameters
Wang LF
Eye 2025; 39: 2042-2050
128813 A comprehensive and systematic review on resveratrol supplementation as a promising candidate for the retinal disease: a focus on mechanisms of action from preclinical studies
Lv XM
Frontiers in pharmacology 2025; 16: 1615910
127269 A multi-omics study reveals molecular characteristics and therapeutic targets of salidroside in reducing TGF-β2-induced ECM expression
Zhang R
Experimental Eye Research 2025; 256: 110386
128813 A comprehensive and systematic review on resveratrol supplementation as a promising candidate for the retinal disease: a focus on mechanisms of action from preclinical studies
Li N
Frontiers in pharmacology 2025; 16: 1615910
127269 A multi-omics study reveals molecular characteristics and therapeutic targets of salidroside in reducing TGF-β2-induced ECM expression
Li N
Experimental Eye Research 2025; 256: 110386
127565 Outcomes of laser peripheral iridotomy in subgroups of primary angle closure disease eyes according to swept-source optical coherence tomography parameters
Xiang HT
Eye 2025; 39: 2042-2050
128813 A comprehensive and systematic review on resveratrol supplementation as a promising candidate for the retinal disease: a focus on mechanisms of action from preclinical studies
Chen LW
Frontiers in pharmacology 2025; 16: 1615910
127269 A multi-omics study reveals molecular characteristics and therapeutic targets of salidroside in reducing TGF-β2-induced ECM expression
Fan Y
Experimental Eye Research 2025; 256: 110386
127565 Outcomes of laser peripheral iridotomy in subgroups of primary angle closure disease eyes according to swept-source optical coherence tomography parameters
Chen SJ; Jiang SM
Eye 2025; 39: 2042-2050
128813 A comprehensive and systematic review on resveratrol supplementation as a promising candidate for the retinal disease: a focus on mechanisms of action from preclinical studies
Sun C
Frontiers in pharmacology 2025; 16: 1615910
127269 A multi-omics study reveals molecular characteristics and therapeutic targets of salidroside in reducing TGF-β2-induced ECM expression
Qing D; Zhao S
Experimental Eye Research 2025; 256: 110386
127565 Outcomes of laser peripheral iridotomy in subgroups of primary angle closure disease eyes according to swept-source optical coherence tomography parameters
Zhang JY
Eye 2025; 39: 2042-2050
127269 A multi-omics study reveals molecular characteristics and therapeutic targets of salidroside in reducing TGF-β2-induced ECM expression
Ren X
Experimental Eye Research 2025; 256: 110386
127565 Outcomes of laser peripheral iridotomy in subgroups of primary angle closure disease eyes according to swept-source optical coherence tomography parameters
Tang XL; Lin H
Eye 2025; 39: 2042-2050
127269 A multi-omics study reveals molecular characteristics and therapeutic targets of salidroside in reducing TGF-β2-induced ECM expression
Wang A
Experimental Eye Research 2025; 256: 110386
127565 Outcomes of laser peripheral iridotomy in subgroups of primary angle closure disease eyes according to swept-source optical coherence tomography parameters
Li N
Eye 2025; 39: 2042-2050
127269 A multi-omics study reveals molecular characteristics and therapeutic targets of salidroside in reducing TGF-β2-induced ECM expression
Gao Z
Experimental Eye Research 2025; 256: 110386
